On March 17, 2016, Morgan Stanley undertook a comprehensive rebalancing of Dr. Priceâ€™s portfolio. In the course of that rebalancing, the advisor purchased 26 shares of Zimmer Biomet, worth $2, 697. 74, on behalf of Dr. Price. 26 shares divided by $2, 697. 